TAVI's unsung hero
The Danish inventor of an aortic valve for transcatheter implantation (TAVI) gains recognition for his achievement by colleagues within the European Society of Cardiology
Embracing a nano-size silken promise
Artificial vascular trees, the growing of heart tissue, nerve regeneration: The World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) held in Vienna this October offered an impressive display of current developments in tissue reconstruction and regeneration, Michael Krassnitzer reports
Nobel Prize awarded to Robert Koch Foundation Laureate
The Robert Koch Foundation congratulates Professor Shinya Yamanaka, the 2008 Robert Koch Award laureate, on being awarded this year’s Nobel Prize in Physiology or Medicine. The award to Yamanaka brings the number of Robert Koch Foundation laureates to receive a Nobel Prize to 11 since 1962.
Tangible Return on EU Investment in Global Health R&D
At the launch of the Policy Cures study ‘Saving Lives and Creating Impact: EU Investment in Poverty-Related and Neglected Diseases’ in Brussels today, DSW (Deutsche Stiftung Weltbevoelkerung) confirmed that EU funding for Global Health Research and Development (R&D) has a direct benefit on both developing countries and the European Union.
Gene therapy restores sense of smell in mice
A team of scientists from Johns Hopkins and other institutions report that restoring tiny, hair-like structures to defective cells in the olfactory system of mice is enough to restore a lost sense of smell.
Aiming to beat infectious diseases
Annick Chapoy reports on plans to create a Centre of Excellence in Marseille, France.
The potent cardiac depressant in our own homes
Scientists state concern for both human and environmental health from a very commonly used antibacterial/antifungal agent. Brenda Marsh reports
Unnerved by denervation
Cardiologists are increasingly concerned about patients with persistent hypertension demanding a new technique, in the absence of clinical proof of its long-term benefit. As more related devices are launched, John Brosky reports on the procedure, drawbacks, and a potential €2 billion market.
Knowing the Enemy
Modern wars will be fought in the cyber zone, targeting an enemy's communications technology to cause critical damage; a Tel Aviv University researcher suggests to employ similar tactics in the battle against cancer.
Hard facts on European drug use
Surveys of drug use form an important basis for the development of effective drug policies, and also for measuring the effectiveness of existing policies. For the first time in history, scientists have now made direct comparisons of illicit drug use in 19 European cities by a cooperative analysis of raw sewage samples.
Diagnostic tests followed by personalized medicine
A new genre of medical tests - which determine whether a medicine is right for a patient's genes - are paving the way for increased use of personalized medicine, according to the cover story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Deadly 2011 E. coli Strain Decoded
The secret to the deadly 2011 E. coli outbreak in Germany has been decoded, thanks to research conducted at Michigan State University.
A heart for jellyfish
In a paper published in ”Nature Biotechnology” on the 22nd of July of 2012 Harvard researchers explain how making a jellyfish from rat DNA can help to solve cardiac problems.
Onset of Type 1 diabetes prevented in mice
Swedish researchers from the Karolinska Institutet managed to prevent onset of Type 1 diabetes in mice genetically susceptible to the disease by injecting them with specifically prepared cells.
The UK pharma industry
In the lead up to further talks on medicine pricing, Stephen Whitehead, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI) has accused the UK government of being too focused on encouraging breakthrough drugs at the expense of significant gains for patients from incremental innovation in medicines. ‘The government wants to target resources at big breakthroughs, but…
1920s drug shifts into today’s alcohol addiction arena
EH Paris correspondent Annick Chapoy, reports on a French study that confirms the relevance of a drug with a long history in the management of other diseases
Music for the eyes
EyeMusic, developed by a team of researchers at the Hebrew University of Jerusalem, employs pleasant musical tones and scales to help the visually impaired "see" using music.
Demystifying pulmonary thromboembolism can change patient management
“With all that has been published in the past year on this subject, we will not lack interesting things to highlight and discuss during this session,” said Martine Remy-Jardin, MD, Head of Cardio-Thoracic Imaging at the University Centre of Lille, who will present an update on CT Imaging for thromboembolic disease on Friday afternoon at ESTI 2012.
Early detection of fungal infection critical for immunocompromised patients
Despite the increasing capabilities of CT to detect or identify disease, fungal infections continue to elude diagnosis by imaging. Paradoxically, a CT examination has been demonstrated to be a powerful tool, helping to identify a probability of infection among immuno-compromised patients early enough to effectively treat the condition.
Technology meets philosophy: dose optimisation
Imaging of the chest is the most common radiological examination worldwide. With the incidence of respiratory problems and lung cancer growing, all radiologists should be familiar with the appropriate imaging protocols. In a field dominated by chest x-ray (CXR) and CT, controlling radiation dose is mandatory.
Shared standards critical in lung cancer screening
Findings from the landmark National Lung screening Trial (NLST) continue to make waves in the United States, and increasingly around the world. The principal investigator for the component of the NLST sponsored by the American College of Radiology Imaging Network (ACRIN), Denise Aberle, MD, said the NLST can provide a road map for public policy regarding lung cancer screening, though she cautions…
The future of thoracic imaging
Will MRI become routine modality? Today, thoracic MRI is rarely performed in Europe. But this will change over the next decade, predicts Professor Hans-Ulrich Kauczor, Medical Director of the Radiology Clinic at University Hospital Heidelberg. He expects Germany to be at the forefront of this development because MRI technology, despite the high costs, is already widely used here and because CT…
Cooperation for better detection and treatment of medical conditions
The Johns Hopkins University (JHU), America’s first research university, in Baltimore, Md., USA, and the Fraunhofer Heinrich Hertz Institute (HHI), a mobile and information technology development leader based in Berlin, Germany, have signed a Memorandum of Understanding to jointly research the innovative medical applications of integrated optical sensors: small, highly sensitive devices with…